Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Good
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
Acrivon, adjusted, article, beneficiary, Bioavailable, carboplatin, cashflow, cellular, Chemistry, clarify, CMC, context, distinct, exploit, faith, interdependent, IRA, Journal, markup, newly, outpace, penalize, perpetual, profound, recoverable, regression, reversal, suppression, Symposium, synergized, thereto, therewith, timeline, Topic, twelve, uncollectability, website, xenograft
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view